-
Key African Anti-Venom About to Permanently Run Out
A particularly effective African anti-venom soon will be completely unavailable because its manufacturer decided it was not profitable. Remaining stocks of the drug expire at the end of June.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
NIH grants $2.3M to development of FeverPhone, a portable disease diagnosis kit
Quick diagnosis of bloodborne diseases can very much be a matter of life and death, but bouncing results off a hospital can take hours or days — so the National Institutes of Health and Cornell University are working on a device called the FeverPhone that could cut that time to as little as 15 minutes.
- Categories
- Health Care, Technology
-
Malaria, HIV/Aids Solutions Win Big At Innovation Prize for Africa
A ground-breaking anti-malarial drug made from natural plant extracts has won the 2016 Innovation Prize for Africa (IPA) today; while software to combat HIV drug-resistance medication and a cheap, simple urine test for malaria were the other big winners.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- innovation
-
GAVI alliance offers matched funds for GSK malaria vaccine pilot
The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline's first-generation malaria vaccine, but only if other organizations promise to match that commitment.
- Categories
- Health Care
- Region
- Europe & Eurasia
-
IISC Innovation All Set To Make Diabetic Healthcare Afforable
While lifestyle changes and regular monitoring of blood glucose levels could reduce life-threatening complications arising from diabetes, glucometer to detect blood-glucose levels are currently expensive and unaffordable for many. Now scientists at the Indian Institute of Science (IISc), Bengaluru, have developed a low-cost glucometer kit to check blood-glucose levels.
- Categories
- Health Care
- Region
- South Asia
-
Patient views highlight potential for Peek smartphone suite to transform eye health
An estimated 285 million people worldwide are visually impaired, of whom 39 million are blind. Up to 80% of blindness and visual impairment is avoidable but a lack of trained specialists and the high cost of buying and transporting the right equipment is a major challenge. This is especially true in rural areas and in the low-income nations of Africa and Asia that share the largest proportion of the burden.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Scientists announce important Zika milestone: First vaccine ready for human trials
Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea’s GeneOne Life Sciences said Monday that they had received approval from U.S. regulators to start testing a DNA vaccine, known as GLS-5700, on humans.
- Categories
- Health Care
-
This company wants to provide clean water, using a plastic bag
Providing clean water to their people is a challenge for developing countries struggling to avert health scares while keeping a lid on costs. Three classmates from Singapore are trying to lend a helping hand, using little more than a plastic bag and a ceramic membrane.
- Categories
- Health Care
- Region
- Asia Pacific
